ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Phase II data from the KarMMa trial for relapsed/refractory multiple myeloma
Dr Nikhil Munshi - Dana Farber Cancer Institute, Boston, USA
Background of the KEYLYNK-007 trial for advanced solid tumours
Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA
Regulating haematopoietic stem cell dormancy and ageing through the netrin-1-neo...
Dr Simon Renders - German Cancer Research Center (DKFZ), Heidelberg, Germany
GMMG-CONCEPT: Isa-KRd in front-line treatment of high-risk myeloma
Prof Katja Weisel - University Medical Center Hamburg-Eppendorf, Hamburg, German...
CARTITUDE-1: JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell th...
Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA
Managing Hodgkin lymphoma during the COVID-19 outbreak
Dr Anna Sureda - Hospitalet de Llobregat, Barcelona, Spain
Working up metastatic NSCLC
Dr Depak Dabkara - Tata Medical Center, Kolkata, India
Where have we got to with cancer treatment?
Prof Alexander Eggermont - Princess Máxima Center for Pediatric Oncology, Utrech...
CART-T cell therapy in young patients with relapsed/refractory ALL
Prof Peter Bader - Universitätsklinikum Frankfurt, Frankfurt, Germany
HSCT: Donor selection for patients with ALL
Prof Sebastian Giebel - The Maria Skłodowska-Curie Institute of Oncology, Gliwic...
Therapy of Ph-positive adult ALL
Prof Oliver Ottmann - Cardiff University, Cardiff, UK
The role of blinatumomab followed by HSCT in paediatric patients with ALL
Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy